ABT
Abbott Laboratories
- Total assets, 2025
- $86.7B
- YoY, 2025
- +6.5%
- 5-year CAGR
- +3.6%
- 10-year CAGR
- +7.7%
Total assets
Total assets by fiscal year
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $86.7B | +6.5% |
| 2024 | $81.4B | +11.2% |
| 2023 | $73.2B | −1.6% |
| 2022 | $74.4B | −1.0% |
| 2021 | $75.2B | +3.6% |
| 2020 | $72.5B | +6.9% |
| 2019 | $67.9B | +1.1% |
| 2018 | $67.2B | −11.9% |
| 2017 | $76.3B | +44.8% |
| 2016 | $52.7B | +27.7% |
| 2015 | $41.2B | +0.1% |
| 2014 | $41.2B | −4.1% |
| 2013 | $43.0B | −36.1% |
| 2012 | $67.2B | +11.5% |
| 2011 | $60.3B | −0.5% |
| 2010 | $60.6B | +15.2% |
| 2009 | $52.6B | +24.0% |
| 2008 | $42.4B | +6.8% |
| 2007 | $39.7B | — |